您的当前位置:首页 > 行业数据 > 申万医药及沪深300PE估值情况(截至2025年12月12日,整体TTM法)
图片属性
图片格式:PNG 图片大小:577KB 图片尺寸:2302*1022
同报告图片
 / 4
申万医药及沪深300PE估值情况(截至2025年12月12日,整体TTM法)_第1页
fCDml7bpl7QgICAgICAgfCDljLvoja/nlJ/niako55Sz5LiHKSBQRSB8IOayqua3sTMwMCBQRSB8CnwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS18CnwgMjAxNOW5tDjmnIggIHwg57qmMzkgICAgICAgICAgICAgIHwg57qmMTAgICAgICAgfAp8IDIwMTXlubQ45pyIICB8IOe6pjc1ICAgICAgICAgICAgICB8IOe6pjE5ICAgICAgIHwKfCAyMDE25bm0OOaciCAgfCDnuqY0NSAgICAgICAgICAgICAgfCDnuqYxNCAgICAgICB8CnwgMjAxN+W5tDjmnIggIHwg57qmNDIgICAgICAgICAgICAgIHwg57qmMTUgICAgICAgfAp8IDIwMTjlubQ45pyIICB8IOe6pjM1ICAgICAgICAgICAgICB8IOe6pjEzICAgICAgIHwKfCAyMDE55bm0OOaciCAgfCDnuqYzMiAgICAgICAgICAgICAgfCDnuqYxMiAgICAgICB8CnwgMjAyMOW5tDjmnIggIHwg57qmNjMgICAgICAgICAgICAgIHwg57qmMTcgICAgICAgfAp8IDIwMjHlubQ45pyIICB8IOe6pjQwICAgICAgICAgICAgICB8IOe6pjE0ICAgICAgIHwKfCAyMDIy5bm0OOaciCAgfCDnuqYyNSAgICAgICAgICAgICAgfCDnuqYxMiAgICAgICB8CnwgMjAyM+W5tDjmnIggIHwg57qmMjggICAgICAgICAgICAgIHwg57qmMTEgICAgICAgfAp8IDIwMjTlubQ45pyIICB8IOe6pjMzICAgICAgICAgICAgICB8IOe6pjEzICAgICAgIHwKfCAyMDI15bm0OOaciCAgfCDnuqYzOCAgICAgICAgICAgICAgfCDnuqYxNSAgICAgICB8CgrotYTmlpnmnaXmupDvvJpXaW5kLCDljY7mupDor4HliLjnoJTnqbbmiYA=
申万医药及沪深300PE估值情况(截至2025年12月12日,整体TTM法)_第2页
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
申万医药及沪深300PE估值情况(截至2025年12月12日,整体TTM法)_第3页
申万医药及沪深300PE估值情况(截至2025年12月12日,整体TTM法)_第4页
申万医药及沪深300PE估值情况(截至2025年12月12日,整体TTM法)_第5页
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
所属报告: 【华源证券】医药行业周报:掘金百亿胶原蛋白市场,建议关注佰仁医疗-251214(14页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠